Show simple item record

dc.contributor.authorPérez-García, Felipe
dc.contributor.authorJimenez-Sousa, Maria Angeles 
dc.contributor.authorGómez-Sánchez, Esther
dc.contributor.authorGonzalo-Benito, Hugo
dc.contributor.authorFernandez-Rodriguez, Amanda 
dc.contributor.authorLorenzo-López, Mario
dc.contributor.authorHeredia-Rodríguez, María
dc.contributor.authorMartínez de Paz, Pedro
dc.contributor.authorGómez-Pesquera, Estefanía
dc.contributor.authorTamayo, Eduardo
dc.contributor.authorResino, Salvador 
dc.date.accessioned2022-05-05T11:52:51Z
dc.date.available2022-05-05T11:52:51Z
dc.date.issued2022
dc.identifier.citationJ Microbiol Immunol Infect. 2022; 55(2022): 540-544..es_ES
dc.identifier.urihttp://hdl.handle.net/20.500.12105/14278
dc.description.abstractWe carried out a retrospective exploratory study on 173 patients who underwent major surgery and developed septic shock after surgery. Our findings suggest that CEACAM7 rs1001578, rs10409040, and rs889365 polymorphisms could influence septic shock-related death in individuals who underwent major surgery.es_ES
dc.description.sponsorshipThis work has been supported by grants given by Instituto de Salud Carlos III (grant number PI15/01451 to ET), “Gerencia de Salud, Consejería de Sanidad, Junta de Castilla y Leon” [grant number GRS 463/A/10 and 773/A/13 to ET], and PFIZER [grant number CT25-ESP01-01 to SR]. MAJS and AFR are supported by “Instituto de Salud Carlos III” [grant numbers CP17CIII/00007 and CP14CIII/00010, respectively]es_ES
dc.language.isoenges_ES
dc.publisherElsevier es_ES
dc.type.hasVersionVoRes_ES
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.subjectCEACAM7es_ES
dc.subjectMajor surgeryes_ES
dc.subjectSNPses_ES
dc.subjectSeptic shockes_ES
dc.subjectSurvivales_ES
dc.titleCEACAM7 polymorphisms predict genetic predisposition to mortality in post-surgical septic shock patientses_ES
dc.typejournal articlees_ES
dc.rights.licenseAttribution-NonCommercial-NoDerivatives 4.0 Internacional*
dc.identifier.pubmedID34657826es_ES
dc.format.volume55es_ES
dc.format.number2022es_ES
dc.format.page540es_ES
dc.identifier.doi10.1016/j.jmii.2021.09.006es_ES
dc.contributor.funderInstituto de Salud Carlos III es_ES
dc.contributor.funderJunta de Castilla y León (España) es_ES
dc.contributor.funderPfizer es_ES
dc.description.peerreviewedes_ES
dc.identifier.e-issn1995-9133es_ES
dc.relation.publisherversionhttps://doi.org/10.1016/j.jmii.2021.09.006es_ES
dc.identifier.journalJournal of Microbiology, Immunology, and Infectiones_ES
dc.repisalud.centroISCIII::Centro Nacional de Microbiologíaes_ES
dc.repisalud.institucionISCIIIes_ES
dc.rights.accessRightsopen accesses_ES
dc.relation.projectFISinfo:fis/Instituto de Salud Carlos III/null/null/Subprograma de proyectos de investigacion en salud (AES 2015). Modalidad proyectos en salud. (2015)/PI15/01451es_ES
dc.relation.projectFISinfo:eu-repo/grantAgreement/ES/CP17CIII/00007es_ES
dc.relation.projectFISinfo:eu-repo/grantAgreement/ES/CP14CIII/00010es_ES


Files in this item

Acceso Abierto
Thumbnail

This item appears in the following Collection(s)

Show simple item record

Attribution-NonCommercial-NoDerivatives 4.0 Internacional
This item is licensed under a: Attribution-NonCommercial-NoDerivatives 4.0 Internacional